Parnell Pharmaceuticals Holdings Ltd
PARNF · OTC
12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | |
|---|---|---|---|---|
| Market Cap | $4 | $8,485 | $2,953 | $4,051 |
| - Cash | $4,483 | $4,028 | $4,510 | $4,401 |
| + Debt | $63,376 | $59,685 | $54,672 | $45,043 |
| Enterprise Value | $58,897 | $64,141 | $53,114 | $44,693 |
| Revenue | $34,166 | $30,000 | $28,994 | $26,548 |
| % Growth | 13.9% | 3.5% | 9.2% | – |
| Gross Profit | $19,265 | $17,520 | $17,390 | $15,523 |
| % Margin | 56.4% | 58.4% | 60% | 58.5% |
| EBITDA | $6,002 | $4,229 | $2,399 | $5,260 |
| % Margin | 17.6% | 14.1% | 8.3% | 19.8% |
| Net Income | -$1,420 | -$15,061 | -$7,182 | $130 |
| % Margin | -4.2% | -50.2% | -24.8% | 0.5% |
| EPS Diluted | -0.049 | -0.81 | -0.4 | 0.007 |
| % Growth | 94% | -102.5% | -5,680.5% | – |
| Operating Cash Flow | $5 | -$5 | $2 | -$1,619 |
| Capital Expenditures | -$1 | -$1 | -$1 | -$2,756 |
| Free Cash Flow | $5 | -$5 | $1 | -$4,375 |